Huntsman’s (NYSE: HUN) shares have had an excellent run up in recent weeks, gaining 10% year-to-date, which also meant a fresh 52-week high in late January. For its shareholders, there could be more in store as the chemical giant checks in with its fourth-quarter numbers next week.
Huntsman has surprised in each of the past four quarters, even when peers failed to deliver. There are reasons to believe it more »
Note: A previous version of this article erroneously referenced a substantial decline in CVR Partners's most recent distribution. While the distribution did decline, it was related to a one time plant turnaround and the company expects the distribution to grow in the future. The article has been adjusted accordingly.
It’s a common investor psychology – a stock that’s craved and raved about suddenly appears expensive once it hits more »
Some stocks don’t even pause to catch a breath. Look at Eastman Chemical’s (NYSE: EMN) wild ride in 2012 – I have lost count of the new highs it created this year. And there’s no stopping it -- the stock hit $65.07 last week -- an all-time high for Eastman.
Many are sulking over the missed opportunity, and the question that’s troubling them is: Will Eastman do an more »
If anyone tells you about a stock that’s trading at a paltry 5 times earnings and is within 20% of its 52-week low, you’d probably jump at the opportunity. I would have done the same, if the industry in which Kronos Worldwide (NYSE: KRO) operates wasn’t so unpredictable.
I think it’s prudent for an investor to get a grip on what’s going on around a more »
Dow Chemical’s (NYSE: DOW) last quarter was a disaster, it is down to cost cutting to save margins, its stock has shed 7% in the past three months, and the downdraft battle only seems to be worsening.
So will Dow buckle under the pressure? It’s prudent to delve deeper before jumping to conclusions. Let’s see how Dow fares.
It’s huge: Dow is the world’s more »
Even before Agrium’s (NYSE: AGU) second-quarter results were out, the market knew what was coming. After all, the fertilizer giant had upgraded its earnings guidance some days back.
What followed was music to investors’ ears. It was Agrium’s strongest second quarter in history. Being a nitrogen player definitely helps, but there are other advantages too, which I feel will take the company far.
The king of nutrients
Nitrogen more »
Record profits and record full-year outlook? Whoa! Pinch me, is it true? When cut backs and caution and slowdown are all I am having for breakfast day in and out, Caterpillar (NYSE: CAT) blew me up with phenomenal second-quarter numbers, throwing all doubts, concerns and pessimism out the window at one go.
It surely can’t get any better. Cat has proved its mettle, and I can’t think of more »
The record U.S. planting season might be well behind us, but its benefits won’t stop spilling over so soon. After Monsanto’s (NYSE: MON) stellar third-quarter results last month, it’s time for chemical major DuPont (NYSE: DD) to steal the show next week. Dupont and planting? Yes. DuPont is fast emerging as an agricultural play since it acquired food company Danisco last year. And this is what more »